Effects of using hydroxychloroquine and azithromycin in the treatment of confirmed COVID-19 positive patients
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/05/024982
- Lead Sponsor
- ALL INDIA INSTITUTE OF MEDICAL SCIENCES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
i)All age group (special: children, all preganant women);
ii)PCR documented SARS-CoV-2 carriage in nasopharyngeal sample at admission whatever their clinical status.
Exclusion Criteria
•Non consented.
•Patients will be excluded if they have a known allergy to hydroxychloroquine /chloroquine and/ or Azithromycin and have any other contraindication to treatment with the study drug(Chloroquine or Azithromycin) including retinopathy, G6PD deficiency and QT prolongation.
•Lactating mothers will be excluded based on their declaration.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method virological clearanceTimepoint: day-6 post-inclusion
- Secondary Outcome Measures
Name Time Method virological clearance overtime during the study period, clinical follow-up (body temperature, respiratory rate, duration of stay at hospital and mortality), and occurrence of side effects.Timepoint: 28 days